ÂÜÀòÂÒÂ×

Donald Chace possesses over 30 years of expertise in bioanalysis, specifically utilizing mass spectrometry for metabolic and newborn screening applications. Currently, Donald serves as Lab Director at Capitainer Inc and Principal Scientist at Capitainer AB, while also contributing as an Affiliate Member of the Best Practices Working Group for mQAQC. Since 2010, Donald has been a Guest Researcher at the Centers for Disease Control and Prevention, focusing on quality assurance and control in newborn screening and molecular biology. Donald's previous roles include Chief Scientific Officer at Medolac Laboratories, Associate Editor for Hindawi Publishing, and Director at Pediatrix Analytical. Donald holds a PhD in Pharmacology and an MSFS in Forensic Toxicology from The George Washington University, alongside a BS in Chemistry from Boston College. Expertise in Dried Blood Spot technology and extensive experience in tandem mass spectrometry development are significant highlights of Donald's career.